FDA Letter API

Northern Fish Products, Inc.

Letter data

Company
Northern Fish Products, Inc.
Recipient
Northern Fish Products, Inc. | United States
Issue date
2018-02-28
Posted date
Not available
FDA office
United States
Subject
Not available
Product
Not available
CMS ID
514554
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Northern Fish Products, Inc. MARCS-CMS 514554 — February 28, 2018 More Warning Letters Warning Letters About Warning and Close-Out Letters Recipient: Northern Fish Products, Inc. United States Issuing Office: United States Seattle District Office 22215 261h Avenue SE, Suite 210 Bothell, Washington 98021 February 28, 2018 CERTIFIED MAIL RETURN RECEIPT REQUESTED Ross R. Swanes, President Northern Fish Products, Inc. P.O. Box 9615 Tacoma, Washington 98409 Dear Mr. Swanes: The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter SEA 17-12, dated April 25, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority.  The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Miriam R. Burbach District Director Program Division Director Content current as of: 03/05/2018